Research Pipeline: New Migraine Therapies in Development
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
- What new preventatives are in development?
- What new acute therapies are in development?
- When can we expect a cure?
Find more about Deborah Friedman, MD and her work here:
Deborah Friedman, MD, MPH, FAAN, FAHS
Neurologist, Headache Specialist & Neuro-ophthalmologist
Dr. Deborah Friedman is a neurologist specializing in headache medicine and neuro-ophthalmology in Dallas, Texas. She was the founding director of the Headache and Facial Pain Program and Cerebrospinal Fluid Dynamics Program at the University of Texas Southwestern Medical Center. She is board certified in neurology and headache medicine, and is a Fellow of the American Academy of Neurology, the American Headache Society, the American Neurological Association, and the North American Neuro-Ophthalmology Society (NANOS).
She served on the board of directors for the American Headache Society and the Southern Headache Society, as a past president of NANOS, and on the steering committee for the Idiopathic Intracranial Hypertension Treatment Trial. She has published over 130 articles in peer-reviewed journals and 27 book chapters. Her key interests are intracranial pressure disorders, migraine, and cluster headache.
Watch at your own pace & get additional expert interview footage when you purchase the 2023 Migraine World Summit. Includes:
- All expert interviews with seperate audio (MP3) files & transcripts
- 30 extended, uncut interview editions with 6.5 hours of bonus expert footage
- Lifetime access with no annual fee
Leave a comment
Back to top